Levosimendan and its metabolite OR-1896 elicit KATP channel-dependent dilation in resistance arteries in vivo. Journal title: Pharmacological Reports Authors: Ildikó Gödény, Piero Pollesello, István Edes, Zoltán Papp, Zsolt Bagi Subject(s):